Switch to:

Beam Therapeutics Other Income (Expense)

: $-7.17 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's other income expense for the Beam Therapeutics's pretax income for the three months ended in Mar. 2020 was $-2.70 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2020 was $-7.17 Mil.


Beam Therapeutics Other Income (Expense) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Other Income (Expense) 0.00 -71.29 -5.47

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Other Income (Expense) Premium Member Only Premium Member Only -1.00 -1.01 -1.60 -1.86 -2.70

Beam Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2020 was -1.005 (Jun. 2019 ) + -1.602 (Sep. 2019 ) + -1.864 (Dec. 2019 ) + -2.7 (Mar. 2020 ) = $-7.17 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Beam Therapeutics Other Income (Expense) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)